ArticleFrontiers in oncology2021

OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.

Jiaxing Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.